BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2017
View Archived Issues
Phase I/II results for olaparib plus temozolomide in small cell lung cancer
Read More
FDA issues complete response letter for baricitinib for moderate to severe rheumatoid arthritis
Read More
Discovery of novel potent and selective EphA4 agonists for the treatment of ALS
Read More
Icon Bioscience submits NDA for Dexycu to treat inflammation associated with cataract surgery
Read More
Oxandrolone induces early puberty in boys with Klinefelter syndrome
Read More
Rigel submits NDA for fostamatinib for chronic ITP
Read More
First-in-human phase I results for YS-110 in advanced CD26-expressing cancers
Read More
FDA grants breakthrough therapy and RMAT designations to RVT-802
Read More
FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin
Read More
ECBI-11 has novel mechanism for disrupting estrogen receptor 1 signaling in breast cancer
Read More
Bristol-Myers Squibb licenses compounds to Biogen and Roche
Read More
Amarantus Bioscience creates new subsidiaries Elto Pharma and MANF Therapeutics
Read More
FDA awards fast track designation to Relmada's d-methadone for major depressive disorder
Read More
Interim results from phase III HAVEN 2 pediatric trial of emicizumab in hemophilia A
Read More
Sun Pharma Advanced Research discovers estrogen receptor antagonists
Read More
Bayer Pharma discloses tankyrase-1 and tankyrase-2 inhibitors
Read More
Shingrix submitted for regulatory review in Japan
Read More
FDA breakthrough therapy designation granted to CTL-019 for adults with DLBCL
Read More
Astex and Cancer Research Technology identify Hdm2-p53 interaction inhibitors
Read More
Motif Bio reports promising topline results from REVIVE-1 trial of icalprim in ABSSSI
Read More
Abide Therapeutics presents Lp-PLA2 and ABHD6 inhibitors
Read More
Faron collaborates with University of Birmingham on clinical trial of Clevegen
Read More
Amgen describes activity of first-in-class Mcl-1 inhibitor AMG-176
Read More
Universite Paris-Est Creteil Val de Marne, INSERM and CNRS patent heme oxygenase activators
Read More
AmpliPhi receives positive feedback from FDA on phase II trial plans for AB-SA01
Read More
HitGen and Pfizer collaborate to build and screen novel DNA-encoded libraries
Read More
Cleveland BioLabs updates entolimod progress
Read More